vs
Addus HomeCare Corp（ADUS）とEnhabit, Inc.（EHAB）の財務データ比較。上の社名をクリックして会社を切り替えられます
Addus HomeCare Corpの直近四半期売上が大きい（$373.1M vs $270.4M、Enhabit, Inc.の約1.4倍）。Addus HomeCare Corpの純利益率が高く（8.0% vs -14.3%、差は22.3%）。Addus HomeCare Corpの前年同期比売上増加率が高い（25.6% vs 4.7%）。Addus HomeCare Corpの直近四半期フリーキャッシュフローが多い（$16.1M vs $3.3M）。過去8四半期でAddus HomeCare Corpの売上複合成長率が高い（15.3% vs 1.5%）
Addus HomeCare Corpは米国に本拠を置く在宅ケアサービスプロバイダーで、高齢者、障がい者、慢性疾患患者を主な対象に、介護補助、在宅医療支援、ホスピスケアを提供しています。米国複数州で事業を展開し、公的保険運営元、民間保険会社、個人顧客と提携してニーズに合わせたサービスを届けています。
Enhabit, Inc.はアメリカ合衆国テキサス州ダラスに本拠を置く在宅医療・終末期ケアサービスプロバイダーです。現在34州に255箇所の在宅医療拠点と110箇所の終末期ケア拠点を展開し、テキサス、アラバマ、フロリダ、ジョージアなどで事業を集中しています。米国で4番目に大きい在宅医療事業者であり、終末期ケア分野でも有数の事業者で、2022年にEncompass Healthから同事業がスピンオフして設立されました。
ADUS vs EHAB — 直接比較
損益計算書 — Q4 2025 vs Q4 2025
| 指標 | | |
|---|---|---|
| 売上 | $373.1M | $270.4M |
| 純利益 | $29.8M | $-38.7M |
| 粗利率 | 33.1% | — |
| 営業利益率 | 11.3% | -12.3% |
| 純利益率 | 8.0% | -14.3% |
| 売上前年比 | 25.6% | 4.7% |
| 純利益前年比 | 52.5% | 15.9% |
| EPS（希薄化後） | $1.62 | $-0.76 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $373.1M | $270.4M | ||
| Q3 25 | $362.3M | $263.6M | ||
| Q2 25 | $349.4M | $266.1M | ||
| Q1 25 | $337.7M | $259.9M | ||
| Q4 24 | $297.1M | $258.2M | ||
| Q3 24 | $289.8M | $253.6M | ||
| Q2 24 | $286.9M | $260.6M | ||
| Q1 24 | $280.7M | $262.4M |
| Q4 25 | $29.8M | $-38.7M | ||
| Q3 25 | $22.8M | $11.1M | ||
| Q2 25 | $22.1M | $5.2M | ||
| Q1 25 | $21.2M | $17.8M | ||
| Q4 24 | $19.5M | $-46.0M | ||
| Q3 24 | $20.2M | $-110.2M | ||
| Q2 24 | $18.1M | $-200.0K | ||
| Q1 24 | $15.8M | $200.0K |
| Q4 25 | 33.1% | — | ||
| Q3 25 | 32.2% | — | ||
| Q2 25 | 32.6% | — | ||
| Q1 25 | 31.9% | — | ||
| Q4 24 | 34.2% | — | ||
| Q3 24 | 31.8% | — | ||
| Q2 24 | 32.5% | — | ||
| Q1 24 | 31.4% | — |
| Q4 25 | 11.3% | -12.3% | ||
| Q3 25 | 9.1% | 6.4% | ||
| Q2 25 | 9.4% | 6.3% | ||
| Q1 25 | 9.0% | 6.1% | ||
| Q4 24 | 9.1% | -16.0% | ||
| Q3 24 | 9.0% | -38.6% | ||
| Q2 24 | 9.1% | 4.3% | ||
| Q1 24 | 8.4% | 4.9% |
| Q4 25 | 8.0% | -14.3% | ||
| Q3 25 | 6.3% | 4.2% | ||
| Q2 25 | 6.3% | 2.0% | ||
| Q1 25 | 6.3% | 6.8% | ||
| Q4 24 | 6.6% | -17.8% | ||
| Q3 24 | 7.0% | -43.5% | ||
| Q2 24 | 6.3% | -0.1% | ||
| Q1 24 | 5.6% | 0.1% |
| Q4 25 | $1.62 | $-0.76 | ||
| Q3 25 | $1.24 | $0.22 | ||
| Q2 25 | $1.20 | $0.10 | ||
| Q1 25 | $1.16 | $0.35 | ||
| Q4 24 | $1.06 | $-0.92 | ||
| Q3 24 | $1.10 | $-2.20 | ||
| Q2 24 | $1.10 | $0.00 | ||
| Q1 24 | $0.97 | $0.01 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | — | $43.6M |
| 総負債低いほど良い | $121.0M | $426.0M |
| 株主資本純資産 | $1.1B | $534.0M |
| 総資産 | $1.4B | $1.2B |
| 負債/資本比率低いほどレバレッジが低い | 0.11× | 0.80× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $43.6M | ||
| Q3 25 | — | $56.9M | ||
| Q2 25 | — | $37.1M | ||
| Q1 25 | $97.0M | $39.5M | ||
| Q4 24 | $98.9M | $28.4M | ||
| Q3 24 | $222.9M | $45.7M | ||
| Q2 24 | $173.3M | $28.5M | ||
| Q1 24 | $76.7M | $36.5M |
| Q4 25 | $121.0M | $426.0M | ||
| Q3 25 | $150.6M | $441.5M | ||
| Q2 25 | $169.1M | $456.9M | ||
| Q1 25 | — | $467.3M | ||
| Q4 24 | $218.4M | $492.6M | ||
| Q3 24 | — | $502.9M | ||
| Q2 24 | — | $512.7M | ||
| Q1 24 | — | $526.7M |
| Q4 25 | $1.1B | $534.0M | ||
| Q3 25 | $1.0B | $566.8M | ||
| Q2 25 | $1.0B | $552.4M | ||
| Q1 25 | $995.4M | $543.2M | ||
| Q4 24 | $970.5M | $523.5M | ||
| Q3 24 | $947.6M | $566.1M | ||
| Q2 24 | $921.7M | $674.3M | ||
| Q1 24 | $725.1M | $672.3M |
| Q4 25 | $1.4B | $1.2B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $1.4B | $1.2B | ||
| Q3 24 | $1.2B | $1.3B | ||
| Q2 24 | $1.1B | $1.4B | ||
| Q1 24 | $1.0B | $1.4B |
| Q4 25 | 0.11× | 0.80× | ||
| Q3 25 | 0.14× | 0.78× | ||
| Q2 25 | 0.17× | 0.83× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | 0.23× | 0.94× | ||
| Q3 24 | — | 0.89× | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | 0.78× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $18.8M | $4.4M |
| フリーキャッシュフロー営業CF - 設備投資 | $16.1M | $3.3M |
| FCFマージンFCF / 売上 | 4.3% | 1.2% |
| 設備投資強度設備投資 / 売上 | 0.7% | 0.4% |
| キャッシュ転換率営業CF / 純利益 | 0.63× | — |
| 直近12ヶ月FCF直近4四半期 | $103.8M | $65.8M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $18.8M | $4.4M | ||
| Q3 25 | $51.3M | $37.8M | ||
| Q2 25 | $22.5M | $10.6M | ||
| Q1 25 | $18.9M | $17.9M | ||
| Q4 24 | $10.4M | $-4.1M | ||
| Q3 24 | $48.5M | $28.4M | ||
| Q2 24 | $18.8M | $9.6M | ||
| Q1 24 | $38.7M | $17.3M |
| Q4 25 | $16.1M | $3.3M | ||
| Q3 25 | $49.3M | $36.2M | ||
| Q2 25 | $21.3M | $8.7M | ||
| Q1 25 | $17.1M | $17.6M | ||
| Q4 24 | $8.7M | $-4.7M | ||
| Q3 24 | $46.6M | $27.7M | ||
| Q2 24 | $17.7M | $8.9M | ||
| Q1 24 | $37.3M | $15.5M |
| Q4 25 | 4.3% | 1.2% | ||
| Q3 25 | 13.6% | 13.7% | ||
| Q2 25 | 6.1% | 3.3% | ||
| Q1 25 | 5.1% | 6.8% | ||
| Q4 24 | 2.9% | -1.8% | ||
| Q3 24 | 16.1% | 10.9% | ||
| Q2 24 | 6.2% | 3.4% | ||
| Q1 24 | 13.3% | 5.9% |
| Q4 25 | 0.7% | 0.4% | ||
| Q3 25 | 0.5% | 0.6% | ||
| Q2 25 | 0.4% | 0.7% | ||
| Q1 25 | 0.6% | 0.1% | ||
| Q4 24 | 0.6% | 0.2% | ||
| Q3 24 | 0.7% | 0.3% | ||
| Q2 24 | 0.4% | 0.3% | ||
| Q1 24 | 0.5% | 0.7% |
| Q4 25 | 0.63× | — | ||
| Q3 25 | 2.24× | 3.41× | ||
| Q2 25 | 1.02× | 2.04× | ||
| Q1 25 | 0.89× | 1.01× | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 2.41× | — | ||
| Q2 24 | 1.04× | — | ||
| Q1 24 | 2.44× | 86.50× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ADUS
| Personal Care | $286.0M | 77% |
| Hospice | $70.0M | 19% |
| Home Health | $17.1M | 5% |
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
